Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Notified -

Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer

Notified -

 Wood Mackenzie appoints new Chief Financial Officer

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=bb6dfea7-d12f-48ff-a9d6-b

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio

BASF Catalysts India Private Limited inaugurates a new RD&A lab for automotive emissions control solutions

AMEC Announces New Chair

Renewables and nascent low-carbon technologies most exposed to high interest rates

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=2cafe198-05f3-42d2-ae4d-f

Global LNG market could split if an EU carbon tax is imposed on imports

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=cbf19bf5-18b8-4dd6-b6e0-7

Boehringer expands production site in Greece for new medicine

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

Wood Mackenzie appoints new Chief Financial Officer